Lateral Sagittal vs Costoclavicular Approach for Ultrasound-Guided Infraclavicular Block

October 22, 2020 updated by: BURHAN DOST, Ondokuz Mayıs University

Lateral Sagittal Versus Costoclavicular Approach for Ultrasound-Guided Infraclavicular Brachial Plexus Block: Comparison of Block Dynamics and Patient Comfort

An ultrasound-guided infraclavicular block performed with the costoclavicular (CC) approach and the lateral sagittal (LS) approach will be compared in patients scheduled for forearm and hand surgery.

Study Overview

Detailed Description

The CC approach is a recently introduced infraclavicular approach that targets three cords (medial, lateral and posterior) located lateral to the axillary artery in the costoclavicular space. Cords in this space are located more superficially than with the classical approach at the lateral infraclavicular fossa and are clustered but maintain a consistent anatomical relationship with each other.

Patients will be divided into two groups:

Group LS: Ultrasound-guided infraclavicular block - lateral sagittal approach (20 ml 0.5% bupivacaine)

Group CC: Ultrasound-guided infraclavicular block - costoclavicular approach (20 ml 0.5% bupivacaine)

Study Type

Interventional

Enrollment (Actual)

109

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Atakum
      • Samsun, Atakum, Turkey, 55139
        • Ondokuz Mayis University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18 years to 65 years
  • Patients scheduled for elective forearm and hand surgeries
  • Patients with American Society of Anesthesiologists (ASA) 1-3

Exclusion Criteria:

  • Patients not consenting/unwilling to participate
  • Age <18 years or >65 years
  • Patients with ASA 4
  • Obesity (BMI >30 kg/m2)
  • Regional anesthesia contraindicated (thrombocytopenia, infection at injection site)
  • Severe renal, cardiac, or hepatic disease
  • History of hypersensitivity or allergy to local anesthetics
  • History of opioid or steroid use for more than 4 weeks
  • History of psychiatric disorders
  • Analgesic treatment in the last 48 hours preoperatively
  • Operations lasting less than 60 minutes and more than 180 minutes
  • Patients who converted to general anesthesia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group LS
Ultrasound-guided infraclavicular block - lateral sagittal approach (20 ml 0.5% bupivacaine)
The US probe will be located medial to the coracoid process in the sagittal plane in the infraclavicular region, and then three cords of the brachial plexus will be viewed. Using the in-plane technique, bupivacaine 0.5% will be administered around the posterior cord (7ml), lateral cord (7ml), and medial cord (6ml).
Other Names:
  • Infraclavicular Block - Lateral Sagittal Approach
Active Comparator: Group CC
Ultrasound-guided infraclavicular block - costoclavicular approach (20 ml 0.5% bupivacaine)
The US probe will be placed parallel to the clavicle in the midclavicular area and tilted toward the cephalad and the axillary artery, and three cords will be viewed. A needle will be forwarded from lateral to medial with the in-plane technique, and 20 ml of bupivacaine 0.5% will be administered at the center of the three cords.
Other Names:
  • Infraclavicular Block - Costoclavicular Approach

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Performance time of the operator
Time Frame: During the block procedure
Time elapsed from when the needle enters the skin after an optimal view is obtained on ultrasound until the block needle exits the skin after the procedure is completed.
During the block procedure
Duration of start of motor block
Time Frame: 45 minutes after the block procedure

Time from when a Lovett score of 5 is seen in at least 1 of 3 cords in the patient extremity on which the operation is being performed, following local anesthetic injection.

Lovett rating scale: 6 = normal muscle strength, 5 = slightly decreased muscle strength, 4 = significantly decreased muscle strength, 3 = slight loss of movement, 2 = significant loss of movement, 1 = near total loss of movement, and 0 = total paralysis.

Motor block cord myotomes will be evaluated as medial cord (thumb adduction = ulnar nerve), lateral cord (elbow flexion = mucocutaneous nerve), and posterior cord (wrist extension = radial nerve).

45 minutes after the block procedure
Start time of the nervous block
Time Frame: 45 minutes after the block procedure
Time from the local injection to when a pin-prick test yields no response in at least 1 of 3 cords in the extremity on which the operation is being performed.
45 minutes after the block procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time of sensory block
Time Frame: Postoperative Day 1
Time when the patient describes pain or when the pin-prick test yields a positive response in the extremity on which the operation is performed.
Postoperative Day 1
Time of motor block
Time Frame: Postoperative Day 1

Time when Lovett score is 2 at any of the 3 dermatomes of the extremity on which the operation is being performed.

Lovett rating scale 6 = normal muscle strength, 5 = slightly decreased muscle strength, 4 = significantly decreased muscle strength, 3 = slight loss of movement, 2 = significant loss of movement, 1 = near total loss of movement, and 0= total paralysis.

Motor block cord myotomes will be evaluated as medial cord (thumb adduction=ulnar nerve), lateral cord (elbow flexion= mucocutaneous nerve), and posterior cord (wrist extension=radial nerve).

Postoperative Day 1
Patient Satisfaction
Time Frame: Postoperative Day 1

The discomfort produced by the procedure will be evaluated using the visual rating scale (VRS) at the end of the operation day.

VRS: 0-100, 0 = no discomfort at all, 100 = excessive discomfort.

Postoperative Day 1
Surgeon Satisfaction
Time Frame: Postoperative Day 1

Surgeon satisfaction will be evaluated at the end of the operation day using the VRS.

VRS: 0-100, 0 = no discomfort at all, 100 = excessive discomfort.

Postoperative Day 1
Number of needle redirections
Time Frame: During the block procedure
Number of needle redirections until target area is reached: number of attempts to withdraw and redirect the needle without total withdrawal from the skin.
During the block procedure
Number of needle attempts
Time Frame: During the block procedure
Number of needle attempts required until target area is reached: number of withdrawals and redirections of the needle with total withdrawal from the skin.
During the block procedure
Number of patients who required a rescue block
Time Frame: 45 minutes after the block procedure
Patients subjected to an additional rescue block due to positivity in a pin-prick test at a sensorial examination 45 minutes after the block procedure; these patients will be recorded.
45 minutes after the block procedure
Time of first analgesic request
Time Frame: Postoperative Day 1
Time at which the first analgesic is requested.
Postoperative Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: BURHAN DOST, Ondokuz Mayıs University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2020

Primary Completion (Actual)

October 1, 2020

Study Completion (Actual)

October 20, 2020

Study Registration Dates

First Submitted

April 19, 2020

First Submitted That Met QC Criteria

April 21, 2020

First Posted (Actual)

April 22, 2020

Study Record Updates

Last Update Posted (Actual)

October 26, 2020

Last Update Submitted That Met QC Criteria

October 22, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia, Local

Clinical Trials on Lateral Sagittal Approach

Subscribe